ClinicalTrials Daily: Immune System Diseases

Newly registered clinical trials every business day, grouped by therapeutic area, plus the week's posted results and status changes

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  
« Previous dayNext day »

4 trials newly registered in Immune System Diseases, first posted 2026-11-20 to 2026-11-21, by therapeutic area, largest first. All areas.

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Immune System Diseases (4)

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Rheumatoid Arthritis
DDY391, Placebo - Rheumatoid Arthritis
Phase 2Not yet recruitingNovartis Pharmaceuticals962027-01-262026-11-20
An Open-label Study to Evaluate the Long-Term Safety and Tolerability of Iptacopan in Patients With Complement Mediated Diseases.
Iptacopan - Complement Mediated Diseases e.g. PNH, IgAN
Phase 3Not yet recruitingNovartis Pharmaceuticals362026-11-162026-11-20
Study to Evaluate the Dose-Dependent Effect of Tirzepatide on Gastric Emptying in Adult Patients With Type 1 Diabetes
Tirzepatide - Diabetes Type I
Phase 1RecruitingFundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal122026-09-272026-11-20
Real-world Evidence of Inebilizumab in IgG4-RD
IgG4-Related Diseases
Not yet recruitingPeking Union Medical College Hospital1002027-01-012026-11-20